Inhibition of HIV type 1 replication by simultaneous infection of peripheral blood lymphocytes with human immunodeficiency virus types 1 and 2

AIDS Research and Human Retroviruses

Volumn 17, Issue 4, 2001, Pages 295-309

  Dern, K ^a   Rubsamen Waigmann H ^b   Unger, R E ^c  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; GAG PROTEIN; PHYTOHEMAGGLUTININ; VIRUS DNA; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

ARTICLE; CELL CULTURE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; VIRUS INHIBITION; VIRUS REPLICATION;

DNA, VIRAL; HIV CORE PROTEIN P24; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HIV-2; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; PHYTOHEMAGGLUTININS; VIRUS REPLICATION;

EID: 0035283057     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220150503672     Document Type: Article

References (44)

1. Genetic diversity of human immunodeficiency virus type 2: Evidence for distinct sequence subtypes with differences in virus biology
2. A prospective study of vertical transmission of HIV-2 in Bissau, Guinea-Bissau
3. Human T-lymphotropic virus type 4 and the human immunodeficiency virus in West Africa
4. Genetic analysis of human immunodeficiency virus type 1 and 2 (HIV-1 and HIV-2] mixed infections in India reveals a recent spread of HIV-1 and HIV-2 from a single ancestor for each of these viruses
5. Clinical, hematologic, and immunologic cross-sectional evaluation of individuals exposed to human immunodeficiency virus type-2 (HIV-2)
6. Reduced rate of disease development after HIV-2 infection as compared to HIV-1
7. Molecular cloning of two West African human immunodeficiency virus type 2 isolates that replicate well in macrophages: A Gambian isolate, from a patient with neurologic acquired immunodeficiency syndrome, and a highly divergent Ghanian isolate
8. Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning
9. Evidence for coinfection by multiple strains of human immunodeficiency virus type 1 subtype B in an acute seroconvertor
10. Dual human immunodeficiency virus type 1 infection and recombination in a dually exposed transfusion recipient
11. Phenotype-associated env gene variation among eight related human immunodeficiency virus type 1 clones: Evidence for in vivo recombination and determinants of cytotropism outside the V3 domain
12. Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil
13. The epidemiology of HIV in India
14. Simultaneous isolation of HIV-1 and HIV-2 from an AIDS patient
15. Mixed human immunodeficiency virus (HIV) infection in an individual: Demonstration of both HIV type I and type 2 proviral sequences by using polymerase chain reaction
16. Natural protection against HIV-1 infection provided by HIV-2
17. Human immunodeficiency virus (HIV) type 2-mediated inhibition of HIV type 1: A new approach to gene therapy of HIV-infection
18. Inhibition of HIV-1 expression by H1V-2
19. Molecular inhibition of HIV type 1 by HIV type 2: Effectiveness in peripheral blood mononuclear cells
20. Superinfection of a defective human immunodeficiency virus type I provirus-carrying T cell clone with vif or vpu mutants gives cytopathic virus particles by homologous recombination
21. Standard conditions of virus isolation reveal biological variability of HIV type 1 in different regions of the world
22. A simple method of estimating fifty per cent endpoints
23. Reversal of HIV-phenotype to fulminant replication on macrophages in perinatal transmission
24. Nucleotide sequence of HIV-2D 194, an isolate from a Gambian case of "neuro-AIDS," which showed excellent growth in macrophages
25. A highly divergent HIV-2-related isolate
26. Isolation of variants of lymphocytopathic retroviruses from the peripheral blood and cerebrospinal fluid of patients with ARC or AIDS
27. Characterization of recombinant gp120 and gp160 from HIV-1: Binding to monoclonal antibodies and soluble CD4
28. Phytohemagglutinin: An initiator of mitosis in cultures of normal human leukocytes
29. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure
30. Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle
31. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
32. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV
33. Interference patterns of human immunodeficiency viruses HIV-1 and HIV-2
34. Human immunodeficiency virus (HIV) type I can superinfect HIV-2-infected cells. Pseudotype virions produced with expanded cellular host range
35. The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures
36. Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes
37. Role of vif in replication of human immunodeficiency virus type 1 in CD4+ T lymphocytes
38. Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles
39. The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: A role for Vif in determining virus host range and cross-species transmission
40. The human immunodeficiency virus type 1-specific protein Vpu is required for efficient virus maturation and release
41. Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor
42. Functional interaction of human immunodeficiency virus type 1 Vpu and Gag with a novel member of the tetratricopeptide repeat protein family
43. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: Evidence for differential gene expression